Bioinformatics Molecular Biology Research 
Drug Target Review
JULY 11, 2025
At the centre of this shift is 10x Genomics – a company building tools that enable researchers to study individual cells and their gene activity, both in isolation and in their original spatial context. From maths and physics to molecular biology Schnall-Levin did not begin in the life sciences. “I
Drug Target Review
JUNE 14, 2025
This ‘silo problem’ can impede innovation and slow research progress. I began in bioinformatics, conducting lab-based genomics work but soon felt the need to dive deeper into the computational side. Ian Kerman (IK): My name is Ian Kerman and I’m currently a data science and AI solutions architect at Certara.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
JUNE 26, 2025
This ‘silo problem’ can impede innovation and slow down research progress. He has developed and delivered technical training programmes, mentored students on AI-focused research projects, and co-founded the Data Science and AI Topical Interest Group with the Society for Laboratory Automation and Screening (SLAS).
Codon
JULY 21, 2025
There's a sharp divide between "impressionistic" research that deals with simple predictions and abstract nouns (merely documenting effects and phenomena) and “mechanical research” that attempts to model what we observe in terms of rules and entities. We need to help the Spinozas of bioinformatics grind out new lenses.
Elrig
APRIL 29, 2024
With a background in Bioinformatics and Computational Biology, she has a keen interest in using technology to solve problems in healthcare and medicine. Miguel Gancedo Rodrigo Miguel Gancedo Rodrigo Research Investigator, Isomorphic Labs My name is Miguel, and I’m from Murcia, Spain.
Drug Target Review
MAY 27, 2024
Caris Discovery, the therapeutic research arm of Caris Life Sciences, was launched to address the paucity of novel oncology drug targets and is uniquely poised to discover first-in-class ADC targets. Can you discuss any recent advancements or breakthroughs in ADC-related research or development that Caris has been involved in?
DrugBaron
NOVEMBER 22, 2022
To enable that research, the team at Methuselah Health needed a proteomics approach that would accurately quantify post-translational modifications across the proteome – and since that didn’t exist, their Chief Technology Officer, David Mosedale, set about creating it.
Expert insights. Personalized for you.
Let's personalize your content